Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01995643 · ClinicalTrials.gov registry record · NA
Acute Effects of Grape Seed Extract on Insulin Sensitivity and Oxidative Stress and Inflammation Markers.
A NA study, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT01995643 is a NA study that has completed, run by Clinical Nutrition Research Center, Illinois Institute of Technology. The registered enrollment target is 13 participants.
The verdict
NCT01995643, a NA study, has completed, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The proposed study aims to investigate that consumption of grape seed extract (GSE) would improve antioxidant status and impaired insulin action following consumption of a pro-oxidative high carbohydrate, high fat (HCHF) meal in healthy human subjects.
Interventions
- DIETARY_SUPPLEMENT Placebo Capsule
- DIETARY_SUPPLEMENT Active Capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2013-10-01 |
| Est. Completion | 2014-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01995643
The ClinicalTrials.gov registry entry for NCT01995643 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Capsule is the first listed.
NCT01995643 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01995643 about?
NCT01995643 is a clinical study titled "Acute Effects of Grape Seed Extract on Insulin Sensitivity and Oxidative Stress and Inflammation Markers.". The proposed study aims to investigate that consumption of grape seed extract (GSE) would improve antioxidant status and impaired insulin action following consumption of a pro-oxidative high carbohydrate, high fat (HCHF) meal in healthy human subjects.
What is the current status of trial NCT01995643?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2013-10-01. Estimated completion is 2014-08-30.
What interventions are being tested in trial NCT01995643?
The interventions under investigation include: Placebo Capsule (DIETARY_SUPPLEMENT), Active Capsule (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01995643?
This trial is sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.